Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma
Carcinoma, Renal Cell
Neoplastic Syndromes, Hereditary
Urinary Bladder Neoplasms
SP from kidney tumors was statistically associated with FH mutations. An expert pathologic assessment of renal tumors will facilitate the clinical identification of HLRCC cases, and this will result in genetic testing and targeted cancer screening for patients and at-risk family members. Cancer 2017. © 2017 American Cancer Society.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency